首页|University Heart & Vascular Center Hamburg Reports Findings in Robotics (Procedural and one-year outcomes of robotic-assisted versus manual percutaneous coronary intervention)
University Heart & Vascular Center Hamburg Reports Findings in Robotics (Procedural and one-year outcomes of robotic-assisted versus manual percutaneous coronary intervention)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Robotics is the subject of a report. According to news originating fromHamburg, Germany, by NewsRx correspondents, research stated, “Robotic-assisted percutaneous coronaryintervention (rPCI) has proven to be feasible and safe. Comparative analyses of rPCI versus manual PCI(mPCI) are scarce.”Our news journalists obtained a quote from the research from University Heart & Vascular CenterHamburg, “We aimed to investigate procedural aspects and outcomes of rPCI using the second-generationCorPath GRX Vascular Robotic System compared with mPCI in patients with chronic coronary syndromeand non-ST-segment elevation myocardial infarction acute coronary syndrome. From January to April2021, 70 patients underwent rPCI at the University Heart & Vascular Center Hamburg-Eppendorf and wererecruited into the INTERCATH study. By propensity score matching, a control cohort of 210 patients whounderwent mPCI from 2015-2021 was identified. Co-primary endpoints were one-year all-cause mortalityand major adverse cardiovascular events (MACE) as a composite of cardiovascular death, unplanned targetlesion revascularisation, myocardial infarction, and stroke. The median age of the patients (n=280) was70.7 (25th percentile-75th percentile: 62.0-78.0) years, and 24.6% were female. The Gensini score (28.5[16.2-48.1] vs 28.0 [15.5-47.0]; p=0.78) was comparable between rPCI versus mPCI. During the PCIprocedure, total contrast fluid volume did not differ, whilst longer fluoroscopy times (20.4 min [13.8-27.2]vs 14.4 min [10.4-24.3]; p=0.001) were documented in the rPCI versus mPCI cohort. After 12 months offollow-up, neither all-cause mortality (p=0.22) nor MACE (p=0.25) differed between the groups. rPCI wasassociated with longer fluoroscopy times compared with mPCI, though without increased use of contrastmedium.”
NETL
NSTL
